| Albert D Roke, MD | |
|
1137 W Penn Ave, Womelsdorf, PA 19567-9770 | |
| (610) 589-2555 | |
| (610) 589-4940 |
| Full Name | Albert D Roke |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1137 W Penn Ave, Womelsdorf, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457357857 | NPI | - | NPPES |
| RO166123 | Other | BLUE SHIELD | |
| 01677801 | Other | CAPITAL BLUE CROSS | |
| 0009142930003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD015708E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert D Roke, MD 1137 W Penn Ave, Womelsdorf, PA 19567-9770 Ph: (610) 589-2555 | Albert D Roke, MD 1137 W Penn Ave, Womelsdorf, PA 19567-9770 Ph: (610) 589-2555 |
News Archive
Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
Kinetic Concepts, Inc. will feature ABThera™ Open Abdomen Negative Pressure Therapy System, the latest addition to the KCI Negative Pressure Technology Platform (NPTP), at the American College of Surgeons' 95th Annual Clinical Congress, Oct. 11-15 in Chicago.
A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.
› Verified 2 days ago
Scott A Dietrich, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1137 W Penn Ave, Womelsdorf, PA 19567 Phone: 610-589-2555 Fax: 610-589-4940 | |
Constanta T Ebro-prokesh, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1137 W Penn Ave, Womelsdorf, PA 19567 Phone: 610-589-2555 Fax: 610-589-4940 | |
Elena O Mccabe, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1137 W Penn Ave, Womelsdorf, PA 19567 Phone: 610-589-2555 Fax: 610-589-4940 |